Neoplasm
Not recruitingStudy of Pembrolizumab for Patients with Advanced Solid Tumors
Study of Pembrolizumab for Patients with Advanced Solid Tumors
- Disease:Neoplasm
- Substances:–
Poland- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Study of Pembrolizumab for Patients with Advanced Solid Tumors
PolandStudy Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer
PolandStudy on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy
PolandStudy on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis
PolandStudy on Selexipag and Bosentan for Children with Pulmonary Arterial Hypertension
PolandStudy of Zilovertamab Vedotin with Drug Combination for Patients with Diffuse Large B-Cell Lymphoma
PolandStudy on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients
PolandStudy on Long-term Safety of Ustekinumab for Children with Crohn's Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis
PolandStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels
PolandStudy Comparing Subcutaneous Pembrolizumab with Hyaluronidase to Intravenous Pembrolizumab and Chemotherapy for First-line Treatment of Metastatic Non-Small Cell Lung Cancer
PolandStudy on the Effects of Obexelimab for Patients with IgG4-Related Disease
PolandStudy on the Effects of Azetukalner in Reducing Focal-Onset Seizures for Patients with Epilepsy
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.